Monday, April 30 | |
| Spotlights of Major Clinical Studies with Expert Commentary | |
|
2:00 PM - 3:06 PM Room 104, Level 1 |
|
| Moderator(s): Stephen G. Ellis, Alan C. Yeung | |
| Discussant(s): Dominick J. Angiolillo, Maurice Buchbinder, Davide Capodanno, David Joel Cohen, Tullio Palmerini, Owen Christopher Raffel, Chiung-Jen Wu | |
| 2:00 PM | ABSORB III, IV, Updated Meta, and More - Expert Future Expectation on Bioabsorbable Scaffolds
Lecturer: Gregg W. Stone
|
| 2:07 PM | Discussion
Discussant(s): Marie-Claude Morice , Stephen G. Ellis
|
| 2:11 PM | Contemporary and Future Metallic DES: What Do We Expect More from Ongoing PCI Trials?
Lecturer: Alan C. Yeung
|
| 2:18 PM | Discussion
Discussant(s): Chiung-Jen Wu , Stephen G. Ellis
|
| 2:22 PM | Rapid Changing TAVR Story: Predicting the Future from Ongoing TAVR Clinical Trials
Lecturer: Eberhard Grube
|
| 2:29 PM | Discussion
Discussant(s): Maurice Buchbinder , Owen Christopher Raffel
|
| 2:33 PM | Why DAPT Trial Not Followed?: Moving Forward Less Duration with Smart DES, De-Escalating Strategy, and P2Y12 Inhibitor Monotherapy
Lecturer: Dominick J. Angiolillo
|
| 2:40 PM | Discussion
Discussant(s): Davide Capodanno , David Joel Cohen
|
| 2:44 PM | Expanding Role of NOAC in PCI/AF, ACS, and Stable ASCVD: Recent Trials and Next Expectations
Lecturer: David Joel Cohen
|
| 2:51 PM | Discussion
Discussant(s): Dominick J. Angiolillo , Tullio Palmerini
|
| 2:55 PM | Multivessel PCI in AMI and Cardiogenic Shock: SHOCK Trial Series Review and Real-World Application
Lecturer: Davide Capodanno
|
| 3:02 PM | Discussion
Discussant(s): Chiung-Jen Wu , Alan C. Yeung
|
| 2018 New Data from AMC; Novel and More with Expert Commentary | |
|
3:06 PM - 4:56 PM Room 104, Level 1 |
|
| Moderator(s): Gary S. Mintz, Patrick W. Serruys, Gregg W. Stone | |
| Discussant(s): Davide Capodanno, Eberhard Grube, John McB. Hodgson, Ik-Kyung Jang, Bernhard Meier, Toshiya Muramatsu, Alan C. Yeung | |
| 3:06 PM | To Treat or Not to Treat for Gray Zone FFR(0.76-0.80)
Lecturer: Seung-Jung Park
|
| 3:13 PM | Discussion
Discussant(s): John McB. Hodgson , Evelyn Regar
|
| 3:17 PM | MAINCOMPARE: 10-Year Long-Term Results
Lecturer: Seung-Jung Park
|
| 3:24 PM | Discussion
Discussant(s): Bernhard Meier , Patrick W. Serruys
|
| 3:28 PM | DECISION-CTO Trial: Updated QOL and Outcome Data
Lecturer: Seung-Whan Lee
|
| 3:35 PM | Discussion
Discussant(s): David Joel Cohen , Toshiya Muramatsu
|
| 3:39 PM | What Is the Best Contemporary DES for Left Main PCI?: In-Depth Analysis Using the Largest DB in the World
Lecturer: Pil Hyung Lee
|
| 3:46 PM | Discussion
Discussant(s): Patrick W. Serruys , Gregg W. Stone
|
| 3:50 PM | Differential Cutoff and Impact of Stent Length and Diameter with Contemporary DES: IRIS-DES Data
Lecturer: Cheol Hyun Lee
|
| 3:57 PM | Discussion
Discussant(s): James Flaherty , Alan C. Yeung
|
| 4:01 PM | Routine Use of Fractional Flow Reserve in Clinical Practice: 5 Years Outcomes
Lecturer: Mineok Chang
|
| 4:08 PM | Discussion
Discussant(s): John McB. Hodgson , Bon-Kwon Koo
|
| 4:12 PM | OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients
Lecturer: Duk-Woo Park
|
| 4:19 PM | Discussion
Discussant(s): Gregg W. Stone , Davide Capodanno
|
| 4:23 PM | FIMA-DEFER Trial: ARB for Plaque Stabilization
Lecturer: Do-Yoon Kang
|
| 4:30 PM | Discussion
Discussant(s): Ik-Kyung Jang , Gary S. Mintz
|
| 4:34 PM | Device Closure Versus Medical Therapy in Patients with Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial
Lecturer: Jae-Kwan Song
|
| 4:41 PM | Discussion
Discussant(s): Teguh Santoso , Bernhard Meier
|
| 4:45 PM | Delicate CT Algorithm for Complication-Zero TAVR Procedure
Lecturer: Do-Yoon Kang
|
| 4:52 PM | Discussion
Discussant(s): Eberhard Grube , John Graydon Webb
|
| TCTAP 2018 - Featured Clinical Research from Abstracts | |
|
4:56 PM - 5:51 PM Room 104, Level 1 |
|
| Moderator(s): Eberhard Grube, Alan C. Yeung | |
| Panelist(s): Robert Bersin, Thierry Lefevre, Marie-Claude Morice, Yoshinobu Onuma, Tullio Palmerini, Teguh Santoso, Kishore Sieunarine | |
| 4:56 PM | [TCTAP A-003] Prognosis and Predictors of Lesion Failure After Left Main Bifurcation Intervention: Pooled Analysis of Korean Multicenter Drug-eluting Stent Cohort
Abstract Presenter: Tae-Min Rhee
|
| 5:03 PM | Discussion
Discussant(s): Alan C. Yeung , Thierry Lefevre
|
| 5:07 PM | [TCTAP A-001] Treatment of Coronary DES Restenosis with a Sirolimus or Paclitaxel Coated Balloon
Abstract Presenter: Rosli Mohd Ali
|
| 5:14 PM | Discussion
Discussant(s): Marie-Claude Morice , Teguh Santoso
|
| 5:18 PM | [TCTAP A-005] Prosthesis-related Clinical Events and Long Term Performance Analysis After Transcatheter Aortic Valve Implantation
Abstract Presenter: Luca Testa
|
| 5:25 PM | Discussion
Discussant(s): Eberhard Grube , Thierry Lefevre
|
| 5:29 PM | [TCTAP A-002] Survival and Adverse Events in Patients with Acute Type B Aortic Dissection Who Received Endovascular Therapy or Medical Management Alone: A Population-based Cohort Study
Abstract Presenter: I-Ming Chen
|
| 5:36 PM | Discussion
Discussant(s): Robert Bersin , Kishore Sieunarine
|
| 5:40 PM | [TCTAP A-004] A Prospective, Multi-center Registry to Assess the Novel Sirolimus-eluting Stent with Unique Fusion Coating for Coronary Revascularization in Real World Population: The en-ABL e-registry
Abstract Presenter: Sameer Dani
|
| 5:47 PM | Discussion
Discussant(s): Yoshinobu Onuma , Tullio Palmerini
|